Evaluating an AI Tool Before You Commit Budget

Vendor figures are not evidence

Every AI product page carries a number, and the number is never about your situation. Accuracy on a benchmark. Average handling time. Proportion of queries resolved. Those come from a dataset the vendor chose, a definition of success they wrote, and a measurement taken before your awkward cases existed. None of that makes them dishonest. It makes them uninformative to you, which is a different problem and the more expensive one.

The gap between a demonstration and a purchase decision is usually one unstructured afternoon of testing on material you actually have. Businesses that skip that stage pay for it later, when the tool works on everything they tried and fails on the thing that mattered.

It helps to be clear about what a supplier can reasonably tell you and what they cannot. They can describe latency, throughput and pricing accurately. They can tell you what the tool was built for. They cannot tell you how it behaves on your data, your edge cases or your reviewers, because those have not met yet. Any evaluation leaning on the vendor for that is not an evaluation.

Write the test down before the trial

The single most useful thing you can do is define the evaluation before you have seen a good answer. Sit down with the two or three people who will use the output and write a short document. It does not need to be long. SmartEdge IT Solutions keeps these as one page per candidate tool, which makes comparing two suppliers a matter of reading two pages rather than reconstructing two conversations.

It should contain the specific tasks the tool is expected to perform, described as tasks rather than as benefits. Not “improve customer response times” but “draft a reply to a delivery-delay complaint using the order record and the courier’s status page”. Then the conditions under which an output counts as a success, written so that a second person would agree with you. Then the outputs that must never appear, which is usually the shorter and more important list: invented policies, invented order details, confident answers to anything clinical, financial or legal.

Decide how the result will be judged, and by whom, before the trial. A test written after a good demonstration has a remarkable ability to produce a good result, because you end up measuring whichever cases happened to work.

Add two operational constraints while you are still in a neutral mood. What data may go into this tool, and what must remain inside your own systems? And what happens to the work if the subscription ends — where does the output live, and can it be exported in a usable form?

Both feel defensive at this stage. They are the two questions that decide whether the purchase is reversible.

Build a small test set from your own work

Testing on vendor sample data tells you whether the tool is competent. It does not tell you whether it is usable, because sample data is clean and yours is not. Twenty or thirty real cases is usually enough to find out.

Take the actual work. Genuine inbound queries with names redacted if needed but the structure left intact. Real documents including the awkward ones: the scanned page with a crooked scan, the invoice in an unusual layout, the message with three questions and a screenshot attached. Include cases you already know are difficult, and include several you know are ordinary, because a tool that handles only the hard cases will not be used.

Gather them from the last few months rather than constructing them today. Recency matters, because it tells you what the real volume looks like and it surfaces the seasonal and one-off situations a hand-picked set misses.

Store the set somewhere it can be reused. It becomes the regression suite when you change provider, when a model version is upgraded or when a retrieval source is swapped. Teams consistently underestimate how many times they will need it in the first year, because these changes happen without anyone in your organisation deciding on them.

Our API integration work usually starts by building something like this set, because an integration written against no test cases is an integration nobody can change safely later.

Measure against your current process, not against nothing

The most misleading comparison available is the one against doing nothing. A tool that drafts a reply in four seconds looks transformative next to no reply at all. The relevant comparison is what a competent person achieves in those four seconds after eight years of doing the job, which is a much less flattering benchmark and the only one that carries information.

So run a baseline. Hand the same cases to the people who do the work now and time the result. You will learn three things. How much of the current time is genuinely unavoidable, such as the part where somebody checks a fact against a live system. How much is waiting, re-reading and re-checking. And where the current process is already fast enough that automation buys nothing at all.

Measure quality as well as speed. Ask the reviewer to score each output without knowing which came from the tool and which from a colleague. Blinding the comparison takes ten minutes of setup and removes most of the argument that follows.

Then look at the distribution rather than the average. A tool that is excellent on most cases and catastrophic on a few will not be trusted, and once trust is gone the review step expands until the saving has gone with it. Averages hide precisely the thing that decides whether you keep it.

Where the tool has to sit inside something you already ship, such as a customer portal, that is a different kind of build — closer to SaaS product development than to buying a subscription, and the cost of evaluation looks different.

The questions only your own team can answer

Suppliers answer product questions well. They cannot answer questions about your organisation, and those decide whether the tool survives its first year.

• What happens to the data after the trial? Retention period, whether it is used for training, and whether deletion is genuinely available or merely requested.
• Where does processing happen, and does that matter to your clients, your contracts or your sector’s rules?
• What happens when the tool is unavailable? Which tasks fall back to a person, and does that person exist at that hour?
• How would we audit what it did six months ago? Is there an exportable log of inputs and outputs containing enough to reconstruct a decision?
• What breaks if we move? Rate limits, model deprecation, format changes, price rises at renewal.
• Who inside the business owns the answer when it is wrong in public?

These are not trick questions. A supplier who answers them directly and in writing is telling you something useful about how they will behave in year two, which is a better signal than anything in a case study.

Cost per successful outcome, not cost per seat

Per-seat pricing flatters tools that are used constantly and quietly. The number that carries information divides total cost by the number of usable results.

Total cost has more lines than the subscription. There is the initial setup, usually larger than expected because it includes cleaning source material and wiring the tool into systems it does not natively understand. There is data preparation. There is integration work if the tool does not already do the thing you need. And there is the review time your team spends correcting output, which is real cost and often the largest single line once things run steadily.

In the assessments SmartEdge IT Solutions carries out, that review line is consistently the one clients have not budgeted for, because it sits in payroll rather than in the invoice.

Then there is the failure path. A wrong answer to a customer is not priced by the vendor. If an error causes a manual correction, a refund or a lost contract, that belongs in the same calculation as the licence, however awkward that conversation feels.

Divide by the number of outputs accepted without material change. That figure is far more informative than either the seat price or the accuracy claim, and it stays meaningful as volume grows in a way the other two do not.

If you would rather model this than guess at it, an AI automation assessment normally starts with exactly this arithmetic rather than with a product comparison.

Run the trial so that it can fail

Most trials are arranged so they succeed. The supplier configures the tool, an internal champion handles the awkward inputs, and the evaluation happens in a calm week when nothing else is on fire. That produces a result which will not reproduce in production, and everyone involved is sincere about believing it.

Design the trial to be uncomfortable. Run it on live work at real volume, including the week when volume doubles. Let the people who will actually use it try it without a champion sitting beside them. Include at least one task you already know it will struggle with, because discovering that during the trial is the entire purpose.

Set a fixed end date at the start and hold the review with the people who will keep using it rather than the person who championed it. Ask them directly what they would stop doing if this disappeared. Disinterest at that point is a reliable signal, and much cheaper to hear in week three than in month nine.

Keep a short weekly log during the trial: what was tried, what failed, what had to be worked around and how long the workaround took. You will not remember it later, and this log becomes the substance of the go or no-go conversation.

Deciding to stop, and keeping the exit cheap

Some trials should end with a decision not to proceed, and that is a good outcome if it happens in month two rather than month fourteen. The most frequent reason is not capability. It is that the underlying process was never stable enough to automate, and no tool fixes that.

Two decisions protect the budget. First, avoid building in a way that only one vendor’s product can serve. Keep your test set, keep intermediate results in a format you own, and put the business logic in code you control rather than in a configuration screen. That sounds fussy and it is what saves the project when a supplier changes pricing or retires a model.

Second, phase the commitment. Begin with the smallest spend that would answer the question, and make the next tranche conditional on something you can observe. Most suppliers understand this and will accommodate it. A supplier who refuses is telling you how the second year will go.

If you want a second opinion before signing anything, an independent strategy consultation is the cheapest hour-per-week money in most of these decisions, particularly when it happens before the contract rather than after it.

The short version: an evaluation should be able to end in “no” at a predictable cost. Write the test, keep the data, watch the awkward cases, and be wary of any supplier who would rather you did not look closely.